Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.

Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Abstract Text:

    qifang shiQifang Shi,michelle m lynchMichelle M Lynch,margarita romeroMargarita Romero,james m burnsJames M Burns,

    The 42-kDa processed fragment of Plasmodium falciparum merozoite surface protein 1 (MSP-1(42)) is a prime candidate for a blood-stage malaria vaccine. Merozoite surface protein 8 contains two C-terminal epidermal growth factor (EGF)-like domains that may function similarly to those of MSP-1(42). Immunization with either MSP-1 or MSP-8 induces protection that is mediated primarily by antibodies against conformation-dependent epitopes. In a series of comparative immunogenicity and efficacy studies using the Plasmodium yoelii rodent model, we tested the ability of recombinant P. yoelii MSP-8 (rPyMSP-8) to complement rPyMSP-1-based vaccines. Unlike MSP-1, PyMSP-8-dependent protection required immunization with the full-length protein and was not induced with recombinant antigens that contained only the C-terminal EGF-like domains. Unlike PyMSP-8, the immunogenicity of the PyMSP-1 EGF-like domains was low when present as part of the rPyMSP-1(42) antigen. Immunization with a mixture of rPyMSP-1(42) and rPyMSP-8 further inhibited the antibody response to protective epitopes of rPyMSP-1(42) and did not improve vaccine efficacy. To improve PyMSP-1 immunogenicity, we produced a chimeric antigen containing the EGF-like domains of PyMSP-1 fused to the N terminus of PyMSP-8. Immunization with the chimeric rPyMSP-1/8 antigen induced high and comparable antibody responses against the EGF-like domains of both PyMSP-1 and PyMSP-8. This enhanced MSP-1-specific antibody response and the concurrent targeting of MSP-1 and MSP-8 resulted in improved, nearly complete protection against lethal P. yoelii 17XL malaria. Unexpectedly, immunization with rPyMSP-1/8 failed to protect against challenge infection with reticulocyte-restricted P. yoelii 17X parasites. Overall, these data establish an effective strategy to improve the efficacy of P. falciparum MSP-based vaccines.

    Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Publishing Authors By Initials

    q shiQ Shi,mm lynchMM Lynch,m romeroM Romero,jm burnsJM Burns,

    For similar complex mixtures: biological products: vaccines: vaccines, subunit research abstracts see: complex mixtures: biological products: vaccines: vaccines, subunit research

    PUBMED ID PMID:

    MEDLINE DATE:

    Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Journal Published:

    PUBLICATION TYPE: Research Support, N.I.H., Extr

    Journal: Infection and immunity

    VOLUME: 75

    Page Numbers: 1349-58

    Journal Abbreviation: Infect. Immun.

    ISSN: 0019-9567

    DAY: 11

    MONTH: 12

    YEAR: 2006

    Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 246127

    Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Keywords Mesh Terms:

    KEYWORDS: Vaccines, Subunit

    MESH TERMS: immunology

    Chemical & Substance for Abstract: Enhanced protection against malaria by a chimeric merozoite surface protein vaccine. Information

    Substance Name: merozoite surface protein 8, Plasmodium

    Registry Number: 0

    Grant and Affiliation Information for Enhanced protection against malaria by a chimeric merozoite surface protein vaccine.

    AFFILIATION: Department of Microbiology and Immunology, Drexel University College of Medicine, 2900 Queen Lane, Philadelphia, PA 19129, USA.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY: United States NIAID

    GRANT: R01AI35661

    ACRONYM: AI

    MEDLINETA: Infect Immun

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Enhanced protection against malaria by a chimeric merozoite surface protein vaccine Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News